Treatment of cervical intraepithelial lesions

Philip E. Castle, Dan Murokora, Carlos Perez, Manuel Alvarez, Swee Chong Quek, Christine Campbell

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Precancerous cervical lesions precede the development of invasive cervical cancer by 10–20 years, making cervical cancer preventable if these lesions are detected and effectively treated. Treatment has evolved in the last few decades and now includes ablative options that can be performed in lower-resource settings where surgical excision is not feasible or routinely available. Gas-based cryotherapy, which freezes cervical tissue to induce localized necrosis, is the most commonly used ablative treatment. However, its implementation in low-resource settings is difficult because the refrigerant gas can be difficult to procure and transport, and is expensive. New cryotherapy devices that do not require an external supply of gas appear promising. Thermal coagulation, which burns cervical tissue to induce necrosis, has become more widely available in the last few years owing to its portability and the feasibility of using battery-powered devices. These two ablative treatments successfully eradicate 75%–85% of high-grade cervical lesions and have minor adverse effects.

Original languageEnglish (US)
Pages (from-to)20-25
Number of pages6
JournalInternational Journal of Gynecology and Obstetrics
Volume138
DOIs
StatePublished - Jul 1 2017

Fingerprint

Cryotherapy
Gases
Uterine Cervical Neoplasms
Necrosis
Equipment and Supplies
Therapeutics
Hot Temperature

Keywords

  • Cervical precancer
  • Cryotherapy
  • Low- and middle-income country
  • Thermal coagulation
  • Treatment

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Treatment of cervical intraepithelial lesions. / Castle, Philip E.; Murokora, Dan; Perez, Carlos; Alvarez, Manuel; Quek, Swee Chong; Campbell, Christine.

In: International Journal of Gynecology and Obstetrics, Vol. 138, 01.07.2017, p. 20-25.

Research output: Contribution to journalArticle

Castle, PE, Murokora, D, Perez, C, Alvarez, M, Quek, SC & Campbell, C 2017, 'Treatment of cervical intraepithelial lesions', International Journal of Gynecology and Obstetrics, vol. 138, pp. 20-25. https://doi.org/10.1002/ijgo.12191
Castle, Philip E. ; Murokora, Dan ; Perez, Carlos ; Alvarez, Manuel ; Quek, Swee Chong ; Campbell, Christine. / Treatment of cervical intraepithelial lesions. In: International Journal of Gynecology and Obstetrics. 2017 ; Vol. 138. pp. 20-25.
@article{7a09963905804a3e8c4c475e209e5ad4,
title = "Treatment of cervical intraepithelial lesions",
abstract = "Precancerous cervical lesions precede the development of invasive cervical cancer by 10–20 years, making cervical cancer preventable if these lesions are detected and effectively treated. Treatment has evolved in the last few decades and now includes ablative options that can be performed in lower-resource settings where surgical excision is not feasible or routinely available. Gas-based cryotherapy, which freezes cervical tissue to induce localized necrosis, is the most commonly used ablative treatment. However, its implementation in low-resource settings is difficult because the refrigerant gas can be difficult to procure and transport, and is expensive. New cryotherapy devices that do not require an external supply of gas appear promising. Thermal coagulation, which burns cervical tissue to induce necrosis, has become more widely available in the last few years owing to its portability and the feasibility of using battery-powered devices. These two ablative treatments successfully eradicate 75{\%}–85{\%} of high-grade cervical lesions and have minor adverse effects.",
keywords = "Cervical precancer, Cryotherapy, Low- and middle-income country, Thermal coagulation, Treatment",
author = "Castle, {Philip E.} and Dan Murokora and Carlos Perez and Manuel Alvarez and Quek, {Swee Chong} and Christine Campbell",
year = "2017",
month = "7",
day = "1",
doi = "10.1002/ijgo.12191",
language = "English (US)",
volume = "138",
pages = "20--25",
journal = "International Journal of Gynecology and Obstetrics",
issn = "0020-7292",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Treatment of cervical intraepithelial lesions

AU - Castle, Philip E.

AU - Murokora, Dan

AU - Perez, Carlos

AU - Alvarez, Manuel

AU - Quek, Swee Chong

AU - Campbell, Christine

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Precancerous cervical lesions precede the development of invasive cervical cancer by 10–20 years, making cervical cancer preventable if these lesions are detected and effectively treated. Treatment has evolved in the last few decades and now includes ablative options that can be performed in lower-resource settings where surgical excision is not feasible or routinely available. Gas-based cryotherapy, which freezes cervical tissue to induce localized necrosis, is the most commonly used ablative treatment. However, its implementation in low-resource settings is difficult because the refrigerant gas can be difficult to procure and transport, and is expensive. New cryotherapy devices that do not require an external supply of gas appear promising. Thermal coagulation, which burns cervical tissue to induce necrosis, has become more widely available in the last few years owing to its portability and the feasibility of using battery-powered devices. These two ablative treatments successfully eradicate 75%–85% of high-grade cervical lesions and have minor adverse effects.

AB - Precancerous cervical lesions precede the development of invasive cervical cancer by 10–20 years, making cervical cancer preventable if these lesions are detected and effectively treated. Treatment has evolved in the last few decades and now includes ablative options that can be performed in lower-resource settings where surgical excision is not feasible or routinely available. Gas-based cryotherapy, which freezes cervical tissue to induce localized necrosis, is the most commonly used ablative treatment. However, its implementation in low-resource settings is difficult because the refrigerant gas can be difficult to procure and transport, and is expensive. New cryotherapy devices that do not require an external supply of gas appear promising. Thermal coagulation, which burns cervical tissue to induce necrosis, has become more widely available in the last few years owing to its portability and the feasibility of using battery-powered devices. These two ablative treatments successfully eradicate 75%–85% of high-grade cervical lesions and have minor adverse effects.

KW - Cervical precancer

KW - Cryotherapy

KW - Low- and middle-income country

KW - Thermal coagulation

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85021960593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021960593&partnerID=8YFLogxK

U2 - 10.1002/ijgo.12191

DO - 10.1002/ijgo.12191

M3 - Article

C2 - 28691333

AN - SCOPUS:85021960593

VL - 138

SP - 20

EP - 25

JO - International Journal of Gynecology and Obstetrics

JF - International Journal of Gynecology and Obstetrics

SN - 0020-7292

ER -